Non-autocrine, constitutive activation of Met in human anaplastic thyroid carcinoma cells in culture

British Journal of Cancer

Volumn 80, Issue 5-6, 1999, Pages 650-656

  Bergstrom J D ^a   Hermansson, A ^a   Diaz De Stahl T ^a   Heldin, N E ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Anaplastic carcinoma; Met; Receptor activation; Thyroid

Indexed keywords

MESSENGER RNA; PROTEIN TYROSINE KINASE;

ANAPLASTIC CARCINOMA; ARTICLE; CARCINOMA CELL; ENZYME ACTIVATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; THYROID CARCINOMA;

EID: 0032897608     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690406     Document Type: Article

References (51)

1. Adams JC, Furlong RA and Watt FM (1991) Production of scatter factor by ndk, a strain of epithelial cells, and inhibition of scatter factor activity by suramin. J Cell Sci 98: 385-394
2. Ain KB and Taylor KD (1994) Somatostatin analogs affects proliferation of human thyroid carcinoma cell lines in vitro. J Clin Endocrinol Metab 78: 1097-1102
3. Auffray C and Rougeon F (1980) Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA. Eur J Biochem 107: 303-314
4. Bardelli A, Maina F, Gout I, Fry MJ, Waterfield MD, Comoglio PM and Ponzetto C (1992) Autophosphorylation promotes complex formation of recombinant hepatocyte growth factor receptor with cytoplasmic effectors containing SH2 domains. Oncogene 7: 1973-1978
5. Bardelli A, Ponzetto C and Comoglio PM (1994) Identification of functional domains in the hepatocyte growth factor and its receptor by molecular engineering. J Biotechnol 37: 109-122
6. Boltaro DP, Rubin JS, Faletto DL, Chan AM-L, Kmiecik TE, Vande Woude GF and Aaronson SA (1991) Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 251: 802-804
7. Börset M, Lien E, Espevik T, Helseth E, Waage A and Sundan A (1996) Concomitant expression of hepatocyte growth factor/scatter factor and its receptor in human myeloma cell lines. J Biol Chem 271: 24655-24661
8. Carlsson J, Nilsson K, Westermark B, Pontén J, Sundström C, Larsson E, Bergh J, Påhlman S, Busch C and Collins VP (1983) Formation and growth of multicellular spheroids of human origin. Int J Cancer 31: 523-533
9. Carcangiu ML, Steeper T, Zampi G and Rosai J (1985) Anaplastic thyroid carcinoma. A study of 70 cases. Am J Clin Pathol 83: 135-158
10. de Juan C, Sánchez A, Nakamura T, Fabregat I and Benito M (1994) Hepatocyte growth factor up-regulates met expression in rat fetal hepatocytes in primary culture. Biochem Biophys Res Commun 204: 1364-1370
11. Di Renzo MF, Narsimhan RP, Olivero M, Bretti S, Giordano S, Medico E, Gaglio P, Zara P and Comoglio PM (1991) Expression of the Met/HGF receptor in normal and neoplastic human tissues. Oncogene 6: 1997-2003
12. Di Renzo MF, Olivero M, Ferro S, Prat M, Bongarzone I, Pilotti S, Belfiore A, Costantino A, Vigneri R, Pierotti MA and Comoglio PM (1992) Overexpression of the c-MET/HGF receptor gene in human thyroid carcinomas. Oncogene 7: 2549-2553
13. Di Renzo MF, Olivero M, Katsaros D, Crepaldi T, Gaglia P, Zola P, Sismondi P and Comoglio PM (1994) Overexpression of the Met/HGF receptor in ovarian cancel. Int J Cancer 58: 658-662
14. Di Renzo MF, Poulsom R, Olivero M, Comoglio PM and Lemoine NR (1995a) Expression of the Met/hepatocyte growth factor receptor in human pancreatic cancer. Cancer Res 55: 1129-1138
15. Di Renzo MF, Olivero M, Serini G, Orlandi F, Pilotti S, Belfiori A, Costantino A, Vigneri R, Angeti A, Pierotti MA and Comoglio PM (1995b) Overexpression of the c-MET/HGF receptor in human thyroid carcinomas derived from the follicular epithelium. J Endocrinol Invest 18: 134-139
16. Dremier S, Taton M, Coulonval K, Nakamura T, Matsumoto K and Dumont JE (1994) Mitogenic, de-differentiating, and scattering effects of hepatocyte growth factor on dog thyroid cells. Endocrinology 135: 135-140
17. Eceles N, Ivan M and Wynford-Thomas D (1996) Mitogenic stimulation of normal and oncogene-transformed human thyroid epithelial cells by hepatocyte growth factor. Mol Cell Endocrinol 117: 247-251
18. Ferracini R, Di Renzo MF, Scotlandi K, Baldini N, Olivero M, Lollini PL, Cremona O, Campanacci M and Comoglio PM (1995) The Met/HGF paracrine or an autocrine circuit. Oncogene 10: 739-749
19. Fixman ED, Fournier TM, Kamikura DM, Naujokas MA and Park M (1996) Pathways downstream of Shc and Grb2 are required for cell transformation by the Tpr-Met oncoprotein. J Biol Chem 271: 13116-13122
20. Gambarolta G, Boccacio C, Giordano S, Ando M, Stella MC and Comoglio PM (1996) Ets up-regulates MET transcription. Oncogene 13: 1911-1917
21. Giordano S, Di Renzo MF, Narsimhan RP, Cooper CS, Rosa C and Comoglio PM (1989) Biosynthesis of the protein encoded by the c-met proto-oncogene. Oncogene 4: 1383-1388
22. Heldin N-E and Westermark B (1988) Epidermal growth factor, but not thyrotropin, stimulates the expression of c-fos and c-myc messenger ribonucleic acid in porcine thyroid follicle cells in primary culture. Endocrinology 122: 1042-1046
23. Heldin N-E, Cvejic D, Smeds S and Westermark B (1991) Coexpression of functionally active receptors for thyrotopin and platelet derived growth factor in human thyroid carcinoma cells. Endocrinology 129: 2187-2193
24. Heldin N-E, Gustavsson B, Claesson-Welsh L, Hammacher A, Mark J, Heldin C-H and Westermark B (1988) Aberrant expression of receptors for platelet derived growth factor in an anaplastic thyroid carcinoma cell line. Proc Natl Acad Sci USA 85: 9302-9306
25. Higashio K, Shima N, Goto M, Itagaki Y, Nagao M, Yasuda H and Morinaga T (1990) Identity of a tumor cytotoxic factor from human fibroblasts and hepatocyte growth factor. Bichem Biophys Res Commun 170: 397-404
26. Ivan M, Bond JA, Prat M, Comoglio PM and Wynford-Thomas D (1997) Activated ras and ret oncogenes induce overexpression of c-met (hepatocyte growth factor receptor) in human thyroid epithelial cells. Oncogene 14: 2417-2423
27. Jeffers M, Schmidt L, Nakaigawa N, Webb CP, Weirich G, Kishida T, Zbar B and Vande Woude GF (1997) Activating mutations for the Met tyrosine kinase receptor in human cancer. Proc Natl Acad Sci USA 94: 11445-11450
28. 1234 1235 are critical for the activation of the tyrosine kinase encoded by the MET proto-oncogene (HGF receptor). Oncogene 9: 49-57
29. Naldini L, Weidner KM, Vigna E, Guadino G, Bardelli A, Ponzetto C, Narsimham RP, Hartmann G, Zarnegar R, Michalopoulos GK, Birchmeier W and Comoglio PM (1991) Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor. EMBO J 10: 2867-2878
30. Nakamura T, Nishizawa T, Hagiya M, Seki T, Shimonishi M, Sugimura A, Tashiro K and Shimizu S (1989) Molecular cloning and expression of human hepatocyte growth factor. Nature 342: 440-443
31. Ponzetto C, Bardelli A, Zhen Z, Maina F, dalla Zonca P, Giordano S, Graziani A, Panayotou G and Comoglio PM (1994) A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family. Cell 77: 261-271
32. Ponzetto C, Giordano S, Peverali F, Della Valle G, Abate M, Vaula G and Comoglio PM (1991) c-met is amplified but not mutated in a cell line with an activated met tyrosine kinase. Oncogene 6: 553-559
33. Prat M, Narsimban R, Crepaldi T, Nicotra R, Natali PG and Comoglio PM (1991) The receptor encoded by the human c-met oncogene is expressed in hepatocytes, epithelial cells and solid tumors. Int J Cancer 49: 323-328
34. Rong S, Bodescot M, Blair D, Dunn J, Nakamura T, Mizuno K, Park M, Chan A, Aaronson S and Vande Woude GF (1992) Tumorigenicity of the met protooncogene and the gene for hepatocyte growth factor. Mol Cell Biol 12: 5152-5158
35. Rong S, Segal S, Anver M, Resau JH and Vande Woude GF (1994) Invasiveness and metastasis of NIH 3T3 cells induced by Met-hepatocyte growth factor/scatter factor autocrine stimulation. Proc Natl Acad Sci USA 91: 4731-4735
36. Rubin JS, Chan AM, Bottaro DP, Burgess WH, Taylor WG, Cech AC, Hirschfield DW, Wong J, Miki T, Finch PW and Aaronsson SA (1991) A broad-spectrum human lung fibroblast-derived mitogen is a variant of hepatocyte growth factor. Proc Natl Acad Sci USA 88: 415-419
37. Rusciano D, Lorenzoni P and Burger MM (1996) Constitutive activation of c-Met in liver metastatic B16 melanoma cells depends on both substrate adhesion and cell density and is regulated by a cytosolic tyrosine phosphatase activity. J Biol Chem 271: 20763-20769
38. Santoro M, Carlomagno F, Romano A, Bottaro DP, Dathan NA, Grieco M, Fusco A, Vecchio G, Matoskova B, Kraus MH and Di Fiore PP (1995) Activation of Ret as a dominant transforming gene by germline mutations of MEN 2A and MEN 2B. Science 267: 381-383
39. Schmidt L, Duh FM, Chen F, Kishida T, Glenn G, Choyke P, Scherer SW, Zhuang Z, Lubensky I, Dean M, Allikmets R, Chidambaram A, Bergerheim UR, Feltis JT, Casadevall C, Zamarron A, Bernues M, Richard S, Lips CJ, Walther MM, Tsui LC, Geil L, Orcutt ML, Stackhouse T, Lipan J, Slife L, Brauch H, Decker J, Niehans G, Hughson MD, Moch H, Storkel S, Lerman MI, Linehan WM and Zbar B (1997) Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nat Genet 16: 68-73
40. Scotlandi K, Baldini N, Oliviero M, Di Renzo MF, Martana M, Manara MC, Comoglio PM and Ferracini R (1996) Expression of Met/hepatocyte growth factor receptor gene and malignant behavior of musculoskeletal tumors. Am J Pathol 149: 1209-1219
41. Stoker M, Gherardi E and Gray J (1987) Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature 327: 239-242
42. Tsao M S, Zhu H, Giaid A, Viallet J, Nakamura T and Park M (1993) Hepatocyte growth factor/scatter factor is an autocrine factor for human normal bronchial epithelial and lung carcinoma cells. Cell Growth & Diff 4: 571-579
43. Tso JY, Sun XH, Kao T, Reece KS and Wu R (1985) Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene. Nucleic Acids Res 13: 2485-2502
44. Tuck AB, Park M, Sterns EE, Boag A and Elliott BE (1996) Coexpression of hepatocyte growth factor and receptor (Met) in human breast carcinoma. Am J Pathol 148: 225-232.
45. Villa-Moruzzi E, Lapi S, Prat M, Gaudino G and Comoglio PM (1993) A protein tyrosine phosphatase activity associated with the hepatocyte growth factor/scatter factor receptor. J Biol Chem 268: 18176-18180
46. Weidner KM, Arakaki N, Hartmann G, Vandekerckhove J, Weingart S, Rieder H, Fonatsch C, Tsubouchi H, Hishida T, Daikuhara Y and Birchmeier W (1991) Evidence for the identity of human scatter factor and human hepatocyte growth factor. Proc Natl Acad Sci USA 88: 7001-7005
47. Weidner KM, Di Cesare S, Sachs M, Brinkmann V, Behrens J and Birchmeier W (1996) Interaction between Gab1 and the c-Met receptor tyrosine kinase is responsible for epithelial morphogenesis. Nature 384: 173-176
48. Westermark K, Karlsson FA and Westermark B (1983) Epidermal growth factor modulates thyroid growth and function in culture. Endocrinology 112: 1680-1686
49. Zarnegar R and Michalopoulos GK (1995) The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis. J Cell Biol 129: 1177-1180
50. Zarnegar R, Muga S, Rahija R and Michalopoulos G (1990) Tissue distribution of hepatopoietin-A: a heparin-binding polypeptide growth factor for hepatocytes. Proc Natl Acad Sci USA 87: 1252-1256
51. Zhen Z, Giordano S, Longati P, Medico E, Campiglio M and Comoglio PM (1994) Structural and functional domains critical for constitutive activation of the HGF-receptor. Oncogene 9: 1691-1697